Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 214, Issue suppl 3, Pages S355-S359
Publisher
Oxford University Press (OUP)
Online
2016-08-11
DOI
10.1093/infdis/jiw241
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses
- (2016) Jonna B. Westover et al. ANTIVIRAL RESEARCH
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- Determination and Therapeutic Exploitation of Ebola Virus Spontaneous Mutation Frequency
- (2015) Kendra J. Alfson et al. JOURNAL OF VIROLOGY
- VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain
- (2015) A. Marzi et al. SCIENCE
- Combating emerging viral threats
- (2015) E. Bekerman et al. SCIENCE
- Cyclosporin A Inhibits the Propagation of Influenza Virus by Interfering with a Late Event in the Virus Life Cycle
- (2015) Itsuki Hamamoto et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- The Combination of Alisporivir plus an NS5A Inhibitor Provides Additive to Synergistic Anti-Hepatitis C Virus Activity without Detectable Cross-Resistance
- (2014) Udayan Chatterji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Pharmacokinetic–Viral Kinetic Model Describes the Effect of Alisporivir as Monotherapy or in Combination With Peg-IFN on Hepatitis C Virologic Response
- (2014) T H T Nguyen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- From Chemical Tools to Clinical Medicines: Nonimmunosuppressive Cyclophilin Inhibitors Derived from the Cyclosporin and Sanglifehrin Scaffolds
- (2014) Zachary K. Sweeney et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
- (2014) Travis K. Warren et al. NATURE
- Cyclophilin A Associates with Enterovirus-71 Virus Capsid and Plays an Essential Role in Viral Infection as an Uncoating Regulator
- (2014) Jie Qing et al. PLoS Pathogens
- Modeling viral kinetics and treatment outcome during alisporivir interferon-free treatment in hepatitis C virus genotype 2 and 3 patients
- (2013) Jeremie Guedj et al. HEPATOLOGY
- Cyclophilins as Modulators of Viral Replication
- (2013) Stephen Frausto et al. Viruses-Basel
- Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus
- (2011) Stephan Ölschläger et al. ANTIVIRAL RESEARCH
- TRIM79α, an Interferon-Stimulated Gene Product, Restricts Tick-Borne Encephalitis Virus Replication by Degrading the Viral RNA Polymerase
- (2011) R. Travis Taylor et al. Cell Host & Microbe
- Cyclosporine Inhibits Flavivirus Replication through Blocking the Interaction between Host Cyclophilins and Viral NS5 Protein
- (2009) M. Qing et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cyclophilin A Levels Dictate Infection Efficiency of Human Immunodeficiency Virus Type 1 Capsid Escape Mutants A92E and G94D
- (2008) L. M. J. Ylinen et al. JOURNAL OF VIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started